Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer

NCT05348161 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05348161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05348161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2019
Completion date
January 1, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive advanced gastric cancer